MATINAS BIOPHARMA HOLDINGS, INC.
Income Statement
| Line Item | FY2015 | FY2014 |
|---|---|---|
| Revenue | $194.5K | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $5.3M | $5.2M |
| SG&A Expense | $4.8M | $5.3M |
| Operating Income | $-9.9M | $-10.5M |
| Operating Margin | -5,096.0% | — |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | — | $270.0K |
| Net Income | $-9.1M | $-10.2M |
| Net Margin | -4,697.0% | — |
| EPS (Basic) | $-0.18 | $-0.32 |
| EPS (Diluted) | $-0.18 | $-0.32 |
| Shares Outstanding (Basic) | 57.2M | 32.3M |
| Shares Outstanding (Diluted) | 57.2M | 32.3M |
| Dividends Per Share | — | — |